Leveraging the Latest Understanding of Viral Vector Immunogenicity to Better Inform Clinical Strategy

Time: 12:15 pm
day: Day 2 CLINICAL AM


  • Highlighting the latest understanding of viral vector immunogenicity seen in the clinical setting
  • Outlining new trends and emerging standards in immune mitigation strategies
  • Guidance for clinical assay selection to monitor the humoral and cellular immune response to a gene therapy